Provenance du réseau au premier degré de Hari Jayaram
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Hari Jayaram via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Sales & Marketing | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
iBASIS, Inc.
 iBASIS, Inc. Specialty TelecommunicationsCommunications iBasis, Inc. provides international voice carrier and value added services for mobile operators. It offers comprehensive portfolio of voice termination and data services, including messaging, signaling and roaming, and mobile operators, as well as voice-over-broadband service providers. The company was founded in 1996 and is headquartered in Lexington, MA. | Specialty Telecommunications | Corporate Officer/Principal | |
Digitas, Inc.
 Digitas, Inc. Miscellaneous Commercial ServicesCommercial Services Digitas, Inc. provides digital and interactive marketing services to the Internet-based and e-commerce companies. The company also provides cross-channel communications to clients. Its services include customer acquisition, cross-sell, loyalty, affinity and customer care operations. The company was founded by Robert L. Cosinuk in 1999 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Vermont | College/University | Undergraduate Degree | |
| AEROVATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| INSULET CORPORATION | Medical Specialties | Director of Finance/CFO | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Biotechnology | Director/Board Member | |
| LYRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Blink Therapeutics, Inc.
 Blink Therapeutics, Inc. BiotechnologyHealth Technology Part of Beam Therapeutics, Inc., Blink Therapeutics, Inc. develops a novel platform to generate therapeutic and diagnostic monoclonal antibodies. The company is based in Wilmington, DE. The CEO of the company is John Evans. | Biotechnology | Chief Executive Officer | |
| PRIME MEDICINE, INC. | Biotechnology | Director/Board Member | |
| BEAM THERAPEUTICS INC. | Biotechnology | Chief Executive Officer | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| SOLID BIOSCIENCES INC. | Biotechnology | Chief Executive Officer | |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Biotechnology | Corporate Officer/Principal | |
| Tufts University | College/University | Graduate Degree | |
| University of New Hampshire | College/University | Undergraduate Degree | |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Flinders University | College/University | Doctorate Degree | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Biotechnology | Chief Executive Officer | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Auburn University | College/University | Undergraduate Degree | |
Rare-X
 Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Packaged Software | Director/Board Member | |
| University of Cambridge | College/University | Graduate Degree | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree | |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Investment Managers | Private Equity Investor | |
| University of Pennsylvania | College/University | Graduate Degree | |
| University of Massachusetts Lowell | College/University | Undergraduate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Public Communications Contact | |
| PURETECH HEALTH PLC | Biotechnology | Director of Finance/CFO | |
| Boston College | College/University | Undergraduate Degree | |
KPMG International Ltd.
 KPMG International Ltd. Miscellaneous Commercial ServicesCommercial Services KPMG International Ltd. is a global organization of independent professional services firms that provide audit, tax, and advisory services. The private company is based in Canary Wharf, UK, and has subsidiaries in Norway and Thailand. The British company operates in 145 countries and territories with more than 236,000 partners and employees working in member firms around the world. KPMG International is a private English company limited by guarantee and each KPMG member firm is responsible for its own obligations and liabilities. The company was founded in 1987, and William Bruce Thomas has been the CEO of the company since 2017. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO |
Statistiques
Internationale
| Etats-Unis | 45 |
| Royaume-Uni | 4 |
| Australie | 2 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 13 |
| Commercial Services | 8 |
| Finance | 3 |
| Communications | 2 |
Opérationnelle
| Director/Board Member | 24 |
| Corporate Officer/Principal | 20 |
| Chief Executive Officer | 11 |
| Undergraduate Degree | 11 |
| Director of Finance/CFO | 9 |
Relations les plus connectées
| Insiders | |
|---|---|
| Sheila Mikhail | 22 |
| John Evans | 12 |
| Allison Dorval | 12 |
| Michael MacLean | 11 |
| Lonnel Coats | 8 |
| Alexander Cumbo | 8 |
| Anthony Philippakis | 7 |
| Joan Nickerson | 6 |
| Troy Lister | 4 |
| Richard Falzone | 3 |
| Julia Chapman | 3 |
- Bourse
- Insiders
- Hari Jayaram
- Connexions Sociétés
